Management of the australianclinicaltrials.gov.au website has been transferred from NHMRC to the Commonwealth Department of Health. Disruption to site users as a consequence of this change should be minimal.

Clinical Trial Details

Adrenergic control of protein and fat metabolism in healthy adults

Print record Print record
Trial Information

Broad Health Condition Metabolic and Endocrine

Specific Health ConditionNormal metabolism and endocrine development and function

Trial FocusPrevention

Recruitment statusRecruiting

Anticipated date of first participant enrolment1/08/2009

Anticipated date of last participant enrolment1/08/2009

Phase of TrialPhase 1

Has the study received ethics approval?Further information iconApproved

Trial summary

The study objective is to investigate the metabolic effects of beta2-agonist in humans, including whole body energy expenditure, fat oxidation, protein synthesis and turnover
Eligibility

Key inclusion criteria

Healthy adults

Minimum age20 Years

Maximum age40 Years

GenderBoth males and females

Can Healthy volunteers participate?Yes

Key exclusion criteria

Any active medical conditions necessitating medication
Contact details and further information

Sponsor Primary Sponsor Type: Government body
Primary Sponsor Name: National Health and Medical Research Council
Primary Sponsor Address: National Health and Medical Research Council National Institute of Clinical Studies GPO Box 4530 Melbourne Vic 3001
Primary Sponsor Country: Australia

Trial websiteNone

Trial IDACTRN12610000161022

Contact person for information and recruitment
Paul Lee
Garvan Institute of Medical Research 384 Victoria Street Darlinghurst New South Wales 2010
+61 2 9295 8486
+61 2 9295 8481
Further information iconp.lee@garvan.org.au
Australia